Michael Petusky

Stock Analyst at Barrington Research

(2.23)
# 2,751
Out of 5,122 analysts
220
Total ratings
39.7%
Success rate
-2.4%
Average return

Stocks Rated by Michael Petusky

Haemonetics
Feb 2, 2026
Maintains: Outperform
Price Target: $93
Current: $65.92
Upside: +41.08%
Option Care Health
Jan 16, 2026
Maintains: Outperform
Price Target: $38$42
Current: $34.19
Upside: +22.84%
Anika Therapeutics
Jan 9, 2026
Maintains: Outperform
Price Target: $16
Current: $10.84
Upside: +47.60%
VerifyMe
Jan 6, 2026
Maintains: Outperform
Price Target: $1$1.5
Current: $1.07
Upside: +40.19%
U.S. Physical Therapy
Jan 5, 2026
Maintains: Outperform
Price Target: $103
Current: $82.74
Upside: +24.49%
DENTSPLY SIRONA
Jan 5, 2026
Maintains: Outperform
Price Target: $14
Current: $12.47
Upside: +12.27%
Merit Medical Systems
Nov 14, 2025
Maintains: Outperform
Price Target: $106
Current: $80.43
Upside: +31.79%
Henry Schein
Nov 5, 2025
Maintains: Outperform
Price Target: $78$79
Current: $75.03
Upside: +5.29%
Orthofix Medical
Nov 5, 2025
Maintains: Outperform
Price Target: $17$18
Current: $12.88
Upside: +39.75%
OPKO Health
Oct 30, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.25
Upside: +80.00%
Maintains: Outperform
Price Target: $95
Current: $86.83
Upside: +9.41%
Downgrades: Market Perform
Price Target: n/a
Current: $7.89
Upside: -